Erlonat 100 – Targeted Lung Cancer Therapy

oncology  /  Erlonat 100

Erlonat 100

Erlonat 100 is a medication with the active ingredient erlotinib hydrochloride at a dosage of 100 mg. It belongs to a group of targeted anticancer drugs known as epidermal growth factor receptor (EGFR... Erlonat 100 is a medication with the active ingredient erlotinib hydrochloride at a dosage of 100 mg. It belongs to a group of targeted anticancer drugs known as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Erlonat 100 is used for the treatment of non-small cell lung cancer with EGFR mutations and pancreatic cancer in patients with progressive disease after chemotherapy. The medication is taken orally in capsule form and works by blocking cancer cell growth, helping to halt tumor progression and improve patient quality of life. Read more Hide

• Active ingredient:
  Erlotinib
• Manufacturer: Natco
• Dosage: 100 mg
• Dosage form: Tablets
• Units per pack: 30
• Delivery across Ukraine
• 100% original product